Randomized phase II study of TS-1/ CPT-11 [irinotecan] versus TS-1/TXL [paclitaxel] in advanced/recurrent gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 Oct 2010 Results presented at the 35th Congress of the European Society for Medical Oncology (ESMO).
- 04 Jun 2010 Final results have been presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 03 Apr 2007 New trial record.